These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35956864)

  • 101. Study of reactivity of cyanoacetohydrazonoethyl-N-ethyl-N-methyl benzenesulfonamide: preparation of novel anticancer and antimicrobial active heterocyclic benzenesulfonamide derivatives and their molecular docking against dihydrofolate reductase.
    Debbabi KF; Al-Harbi SA; Al-Saidi HM; Aljuhani EH; Abd El-Gilil SM; Bashandy MS
    J Enzyme Inhib Med Chem; 2016; 31(sup4):7-19. PubMed ID: 27557134
    [TBL] [Abstract][Full Text] [Related]  

  • 102. CK2 Inhibition and Antitumor Activity of 4,7-Dihydro-6-nitroazolo[1,5-a]pyrimidines.
    Lyapustin DN; Kotovskaya SK; Butorin II; Ulomsky EN; Rusinov VL; Babkov DA; Pokhlebin AA; Spasov AA; Melekhin VV; Tokhtueva MD; Shcheglova AV; Makeev OG
    Molecules; 2022 Aug; 27(16):. PubMed ID: 36014483
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Novel tetrakis-phthalocyanines bearing pyrimidine derivative: crystal XRD analysis, enzyme inhibition, molecular docking, and anticancer effects.
    Günsel A; Yazar B; Taslimi P; Erden Y; Taskin-Tok T; Pişkin H; Bilgiçli AT; Yarasir MN; Gülçin İ
    J Biomol Struct Dyn; 2023 Jan; 41(1):249-262. PubMed ID: 34806542
    [TBL] [Abstract][Full Text] [Related]  

  • 104. An Appraisal on Synthetic and Medicinal Aspects of Fused Pyrimidines as Anti Neoplastic Agents.
    Rani I; Kaur N; Goyal A; Sharma M
    Anticancer Agents Med Chem; 2023; 23(5):525-561. PubMed ID: 35786337
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Synthesis, DFT, and
    Alshaye NA; Alharbi NS; El-Atawy MA; El-Zawawy RO; Hamed EA; Elhag M; Ahmed HA; Omar AZ
    Heliyon; 2024 Jul; 10(14):e34540. PubMed ID: 39130476
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Design, Synthesis, Characterization, and Cytotoxicity of New Pyrazolylmethylene-2-thioxoimidazolidin-4-one Derivatives towards Androgen-Sensitive LNCaP Prostate Cancer Cells.
    El-Atawy MA; Kebeish R; Almotairy ARZ; Omar AZ
    Biomolecules; 2024 Jul; 14(7):. PubMed ID: 39062524
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Design, synthesis,
    Gariganti N; Bandi A; Gatta KRSN; Pagag J; Guruprasad L; Poola B; Kottalanka RK
    Heliyon; 2024 May; 10(9):e30292. PubMed ID: 38711664
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Design, Synthesis and Biological Assessment of
    Alshaye NA; Elgohary MK; Elkotamy MS; Abdel-Aziz HA
    Pharmaceuticals (Basel); 2024 Feb; 17(2):. PubMed ID: 38399431
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Synthesis, Characterization, Antioxidant, and Anticancer Activity against Colon Cancer Cells of Some Cinnamaldehyde-Based Chalcone Derivatives.
    El-Atawy MA; Hanna DH; Bashal AH; Ahmed HA; Alshammari EM; Hamed EA; Aljohani AR; Omar AZ
    Biomolecules; 2024 Feb; 14(2):. PubMed ID: 38397453
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Functionalization Strategies for Electropolishing Process of Carbon Steel Using Novel Quinazoline-4-one Derivatives: Synthesis, Spectroscopic Characterization, and DFT Studies.
    Moustafa AHE; Seleim SM; Abdel-Rahman HH; Embaby AM; Omar AZ
    ACS Omega; 2023 Aug; 8(34):30949-30965. PubMed ID: 37663470
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Synthesis of New Liquid-Crystalline Compounds Based on Terminal Benzyloxy Group: Characterization, DFT and Mesomorphic Properties.
    Omar AZ; Alazmi ML; Alsubaie MS; Hamed EA; Ahmed HA; El-Atawy MA
    Molecules; 2023 Apr; 28(9):. PubMed ID: 37175214
    [TBL] [Abstract][Full Text] [Related]  

  • 112. 2-Anilinopyrimidine derivatives: Design, synthesis, in vitro anti-proliferative activity, EGFR and ARO inhibitory activity, cell cycle analysis and molecular docking study.
    AboulWafa OM; Daabees HMG; Badawi WA
    Bioorg Chem; 2020 Jun; 99():103798. PubMed ID: 32247112
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Pyrimidines-Based Heterocyclic Compounds: Synthesis, Cytoxicity Evaluation and Molecular Docking.
    El-Atawy MA; Alshaye NA; Elrubi N; Hamed EA; Omar AZ
    Molecules; 2022 Aug; 27(15):. PubMed ID: 35956864
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Identification of new 5-(2,6-dichlorophenyl)-3-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidine-7-carboxylic acids as p38α MAPK inhibitors: Design, synthesis, antitumor evaluation, molecular docking and in silico studies.
    El-Wakil MH; El-Dershaby HA; Ghazallah RA; El-Yazbi AF; Abd El-Razik HA; Soliman FSG
    Bioorg Chem; 2024 Apr; 145():107226. PubMed ID: 38377818
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Molecular Dynamics and Biological Evaluation of 2-chloro-7-cyclopentyl- 7H-pyrrolo[2,3-d]pyrimidine Derivatives Against Breast Cancer.
    Singaram K; Marimuthu D; Baskaran S; Chinaga SK; Shanmugarajan D; Vadivel T
    Comb Chem High Throughput Screen; 2017; 20(8):703-712. PubMed ID: 28738766
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
    Maher M; Kassab AE; Zaher AF; Mahmoud Z
    Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
    [TBL] [Abstract][Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.